ANDA 218519, held by Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,. Apixaban.
As of Nov 15, 2026, ANDA 218519 (Apixaban), held by Fosun Wanbang (Jiangsu) Pharmaceutical Group Co.,, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Dec 19, 2025 | Original application | Tentative approval | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters
